PDF icon Download PDF
J Neurol Surg A Cent Eur Neurosurg 2019; 80(06): 475-487
DOI: 10.1055/s-0039-1692976
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Markers for Identifying and Targeting Glioblastoma Cells during Surgery

Stephanie Schipmann 
1   Department of Neurosurgery, University Hospital Münster, Münster, Germany
,
Michael Schwake
1   Department of Neurosurgery, University Hospital Münster, Münster, Germany
,
Eric Suero Molina
1   Department of Neurosurgery, University Hospital Münster, Münster, Germany
,
Walter Stummer
2   NCH, UK Münster, Münster, Germany
› Author Affiliations
Further Information

Publication History

30 December 2018

04 March 2019

Publication Date:
29 August 2019 (online)

Also available ateRefMedOne
  Permissions and Reprints
Preview

Abstract

Glioblastoma is a highly malignant tumor with a poor prognosis. A factor influencing survival that can be affected by the surgeon is the extent of resection (EOR). Due to the infiltrative nature of the tumor, delineation of tumor from normal brain parenchyma is often challenging. To improve EOR and facilitate tumor visualization, several techniques have been developed over the last few years. This literature review presents an overview of current intraoperative strategies for identifying and targeting glioma cells and discusses the benefits and limitations of each technique. Along with conventional techniques such as neuronavigation and ultrasound, fluorescence-guided surgery with different fluorescent agents such as 5-aminolevulinc acid and fluorescein have been widely used. Recently, newer techniques have emerged and are being translated into the operating room, promising delineation of glioblastoma tissue using targeted approaches or identification on a microscopic level, for instance using Raman spectroscopy or confocal microscopy.

Keywords

glioma - interoperative MRI - 5-ALA - fluorescein - indocyanine green